DekaBank Deutsche Girozentrale - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q1 2024. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$218
-0.9%
2,6570.0%0.00%
Q1 2024$220
-2.7%
2,6570.0%0.00%
Q4 2023$226
-5.4%
2,6570.0%0.00%
-100.0%
Q3 2023$239
+191.5%
2,657
+172.8%
0.00%
Q2 2023$82
-100.0%
974
-51.1%
0.00%
-100.0%
Q1 2021$220,000
-5.6%
1,9920.0%0.00%0.0%
Q4 2020$233,000
-84.6%
1,992
-85.5%
0.00%
-88.9%
Q1 2019$1,513,0000.0%13,7490.0%0.01%0.0%
Q3 2018$1,513,000
+45.8%
13,749
+18.7%
0.01%
+28.6%
Q2 2018$1,038,00011,5840.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2024
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders